drugs, medical devices and vaccines to market, the commissioner of
the US Food and Drug Administration stressed in a speech delivered
yesterday (September 16th) in Philadelphia.
Margaret Hamburg, the former New York City health commissioner who
was named FDA commissioner earlier this year, was speaking at the
annual Regulatory Affairs Professional Society conference to
approximately 850 representatives from pharmaceutical companies,
biotechs, and medical device manufacturers.
"Just as biomedical research has evolved in the past decades,
regulatory science -- the science and tools we use to assess and
evaluate product safety, efficacy, potency, quality and performance
-- must also evolve," she said.
Read the full article at
http://www.the-scientist.com/blog/display/55984/
[AOL: <a href="http://www.the-scientist.com/blog/display/55984/">Here</a>]
---------------------------------------------
Send posts to CO-CURE@listserv.nodak.edu
Unsubscribe at http://www.co-cure.org/unsub.htm
Too much mail? Try a digest version. See http://www.co-cure.org/digest.htm
---------------------------------------------
Co-Cure's purpose is to provide information from across the spectrum of
opinion concerning medical, research and political aspects of ME/CFS and/or
FMS. We take no position on the validity of any specific scientific or
political opinion expressed in Co-Cure posts, and we urge readers to
research the various opinions available before assuming any one
interpretation is definitive. The Co-Cure website <www.co-cure.org> has a
link to our complete archive of posts as well as articles of central
importance to the issues of our community.
---------------------------------------------
